- Home
- YMAB vs MPV Comparison
YMAB vs MPV Comparison
Compare YMAB & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- MPV
- Stock Information
- Founded
- YMAB 2015
- MPV 1988
- Country
- YMAB United States
- MPV United States
- Employees
- YMAB N/A
- MPV N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- MPV Finance Companies
- Sector
- YMAB Health Care
- MPV Finance
- Exchange
- YMAB Nasdaq
- MPV Nasdaq
- Market Cap
- YMAB 218.4M
- MPV 183.8M
- IPO Year
- YMAB 2018
- MPV N/A
- Fundamental
- Price
- YMAB $3.89
- MPV $17.23
- Analyst Decision
- YMAB Buy
- MPV
- Analyst Count
- YMAB 11
- MPV 0
- Target Price
- YMAB $18.73
- MPV N/A
- AVG Volume (30 Days)
- YMAB 216.5K
- MPV 25.2K
- Earning Date
- YMAB 05-13-2025
- MPV 01-01-0001
- Dividend Yield
- YMAB N/A
- MPV 8.71%
- EPS Growth
- YMAB N/A
- MPV N/A
- EPS
- YMAB N/A
- MPV 1.71
- Revenue
- YMAB $87,685,000.00
- MPV N/A
- Revenue This Year
- YMAB N/A
- MPV N/A
- Revenue Next Year
- YMAB $18.83
- MPV N/A
- P/E Ratio
- YMAB N/A
- MPV $9.35
- Revenue Growth
- YMAB 3.38
- MPV N/A
- 52 Week Low
- YMAB $3.84
- MPV $11.18
- 52 Week High
- YMAB $17.47
- MPV $16.42
- Technical
- Relative Strength Index (RSI)
- YMAB 40.44
- MPV 57.52
- Support Level
- YMAB $3.76
- MPV $16.52
- Resistance Level
- YMAB $4.60
- MPV $17.45
- Average True Range (ATR)
- YMAB 0.33
- MPV 0.31
- MACD
- YMAB -0.02
- MPV -0.01
- Stochastic Oscillator
- YMAB 15.12
- MPV 76.34
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.